在PAD4抑制中绘制好处,风险和机会
Caio Santos Bonilha1, Flavio Protasio Veras2,3
1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Frontiers in immunology
|March 16, 2026
概括
丁丁氨酸减小酶4 (PAD4) 抑制会影响炎症和免疫反应. 了解其广泛的影响对于平衡免疫媒介疾病中的治疗益处与风险至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 丁丁丁氨酸减小酶4 (PAD4) 是炎症性疾病的标,主要用于抑制中性粒细胞外细胞陷 (NET) 的形成.
- PAD4活性通过非歇斯顿蛋白的素化影响了NET以外的免疫调节,影响了抗原呈现和适应性免疫.
研究的目的:
- 通过利益-风险-机会框架审查PAD4向.
- 分析PAD4在调节各种疾病背景下的炎症病理和免疫反应中的作用.
主要方法:
- 文献综述整合酶特异性,细胞背景和疾病设置.
- 分析PAD4在减轻炎症和潜在地破坏宿主防御方面的双重作用.
主要成果:
- 通过抑制NETs,PAD4抑制有利于血栓炎性疾病.
- 风险包括微生物控制受损,而对树突细胞和T细胞的影响可能会在自身免疫中发挥作用.
- 免疫效应与依赖于素的调节通路的破坏有关,而不仅仅是非目标抑制.
结论:
- 针对PAD4的向需要一种上下文意识的方法,考虑到其广泛的免疫效应.
- 机理性理解有助于选择指示,设计组合疗法,并定义免疫媒介疾病的安全终点.
相关概念视频
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
60
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
60
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Targets for Drug Action: Overview
11.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Pharmacodynamics: Overview and Principles
3.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.8K


